Frequently Asked Questions Why would this medication affect B12 levels at all
Retatrutide Half-Life: What Clinical Data Shows Early pharmacokinetic studies suggest that Retatrutide has a half-life of approximately 68 days, placing it in the same range as other long-acting incretin-based therapies
In addition to boosting insulin release, these medications contribute to better blood sugar management by suppressing the secretion of glucagon, a hormone that typically signals the liver to release stored glucose into the bloodstream
Plastic syringes are not designed for long-term storage of peptides
Qin M, Huang Z, Huang Y, Huang X, Chen C, Wu Y, et al
Best Practices for Patient Education and Support Educating patients about Semaglutide and its potential effects on the liver is essential